Trial Profile
A Non-Randomized, Oppen-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Alimera Sciences
- 17 Jun 2015 New trial record